Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Blockade of the endocannabinoid system for the reduction of cardiometabolic risk factors.

Samaha FF, Chou CM.

Obesity (Silver Spring). 2009 Feb;17(2):220-5. doi: 10.1038/oby.2008.476. Epub 2008 Nov 27. Review. No abstract available.

PMID:
19039319
2.

Effect of PCI on quality of life in patients with stable coronary disease.

Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group, Mancini GB.

N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771.

3.

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.

Schelleman H, Chen J, Chen Z, Christie J, Newcomb CW, Brensinger CM, Price M, Whitehead AS, Kealey C, Thorn CF, Samaha FF, Kimmel SE.

Clin Pharmacol Ther. 2008 Sep;84(3):332-9. doi: 10.1038/clpt.2008.101. Epub 2008 Jul 2.

4.

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia.

Samaha FF, McKenney J, Bloedon LT, Sasiela WJ, Rader DJ.

Nat Clin Pract Cardiovasc Med. 2008 Aug;5(8):497-505. doi: 10.1038/ncpcardio1250. Epub 2008 May 27.

PMID:
18506154
5.

Low-carbohydrate diets, obesity, and metabolic risk factors for cardiovascular disease.

Samaha FF, Foster GD, Makris AP.

Curr Atheroscler Rep. 2007 Dec;9(6):441-7. Review.

PMID:
18377783
6.

Adipocytokine changes caused by low-carbohydrate compared to conventional diets in obesity.

Seshadri P, Samaha FF, Stern L, Ahima RS, Daily D, Iqbal N.

Metab Syndr Relat Disord. 2005;3(1):66-74. doi: 10.1089/met.2005.3.66.

PMID:
18370712
7.

Social support and self-care of patients with heart failure.

Sayers SL, Riegel B, Pawlowski S, Coyne JC, Samaha FF.

Ann Behav Med. 2008 Feb;35(1):70-9. doi: 10.1007/s12160-007-9003-x. Epub 2008 Feb 20.

PMID:
18347906
8.

Clinical exacerbations as a surrogate end point in heart failure research.

Sayers SL, Riegel B, Goldberg LR, Coyne JC, Samaha FF.

Heart Lung. 2008 Jan-Feb;37(1):28-35. doi: 10.1016/j.hrtlng.2007.02.002.

PMID:
18206524
9.

Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study.

Parker CS, Chen Z, Price M, Gross R, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Kimmel SE.

J Gen Intern Med. 2007 Sep;22(9):1254-9. Epub 2007 Jun 22.

10.

Dyslipidemia in type 2 diabetes mellitus.

Gadi R, Samaha FF.

Curr Diab Rep. 2007 Jun;7(3):228-34. Review.

PMID:
17547840
11.

New international measuring stick for defining obesity in non-Europeans.

Samaha FF.

Circulation. 2007 Apr 24;115(16):2089-90. No abstract available.

12.

Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians.

Schelleman H, Chen Z, Kealey C, Whitehead AS, Christie J, Price M, Brensinger CM, Newcomb CW, Thorn CF, Samaha FF, Kimmel SE.

Clin Pharmacol Ther. 2007 May;81(5):742-7. Epub 2007 Feb 28.

PMID:
17329985
13.

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.

Kealey C, Chen Z, Christie J, Thorn CF, Whitehead AS, Price M, Samaha FF, Kimmel SE.

Pharmacogenomics. 2007 Mar;8(3):217-25.

PMID:
17324110
14.

The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Gross R.

Arch Intern Med. 2007 Feb 12;167(3):229-35.

PMID:
17296877
15.

Novel platelet and vascular roles for immunoreceptor signaling.

Samaha FF, Kahn ML.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2588-93. Epub 2006 Oct 5. Review.

16.

Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.

Samaha FF, Szapary PO, Iqbal N, Williams MM, Bloedon LT, Kochar A, Wolfe ML, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):624-30. Epub 2005 Dec 15.

17.

Cost-effectiveness of a low-carbohydrate diet and a standard diet in severe obesity.

Tsai AG, Glick HA, Shera D, Stern L, Samaha FF.

Obes Res. 2005 Oct;13(10):1834-40.

PMID:
16286532
18.

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.

Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. Epub 2005 Nov 10.

19.

Effect of very high-fat diets on body weight, lipoproteins, and glycemic status in the obese.

Samaha FF.

Curr Atheroscler Rep. 2005 Nov;7(6):412-20. Review.

PMID:
16255998
20.

Serum resistin is not associated with obesity or insulin resistance in humans.

Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FF.

Eur Rev Med Pharmacol Sci. 2005 May-Jun;9(3):161-5.

PMID:
16080635
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk